(2S)-3-hydroxy-2-[[(2S,4R)-4-hydroxypyrrolidine-2-carbonyl]amino]propanoic acid

ID: ALA4460144

Chembl Id: CHEMBL4460144

PubChem CID: 10198309

Max Phase: Preclinical

Molecular Formula: C8H14N2O5

Molecular Weight: 218.21

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)[C@H](CO)NC(=O)[C@@H]1C[C@@H](O)CN1

Standard InChI:  InChI=1S/C8H14N2O5/c11-3-6(8(14)15)10-7(13)5-1-4(12)2-9-5/h4-6,9,11-12H,1-3H2,(H,10,13)(H,14,15)/t4-,5+,6+/m1/s1

Standard InChI Key:  UVSBYUFDCGZIMR-SRQIZXRXSA-N

Associated Targets(Human)

SLC15A1 Tchem Oligopeptide transporter small intestine isoform (922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Slc15a1 Solute carrier family 15 member 1 (124 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jejunum (110 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 218.21Molecular Weight (Monoisotopic): 218.0903AlogP: -2.73#Rotatable Bonds: 4
Polar Surface Area: 118.89Molecular Species: ZWITTERIONHBA: 5HBD: 5
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.34CX Basic pKa: 9.11CX LogP: -5.30CX LogD: -5.31
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.35Np Likeness Score: 0.78

References

1. Jiang Q, Zhang J, Tong P, Gao Y, Lv Y, Wang C, Luo M, Sun M, Wang J, Feng Y, Cao L, Wang G, Wang Y, Kan Q, Zhang T, Wang Y, Liu K, Sun J, He Z..  (2019)  Bioactivatable Pseudotripeptidization of Cyclic Dipeptides To Increase the Affinity toward Oligopeptide Transporter 1 for Enhanced Oral Absorption: An Application to Cyclo(l-Hyp-l-Ser) (JBP485).,  62  (17): [PMID:31393124] [10.1021/acs.jmedchem.9b00358]
2. Jiang Q, Xu Q, Wang Y, Li P, Zhang Y, Wang Y, Sun J, Zhang T, He Z..  (2022)  Modulation of Naturally Occurring Linear Dipeptide Chirality to Reduce the Affinity for Oligopeptide Transporter 1 and Increase Intestinal Stability for an Enhanced Colon-Targeting Effect in the Treatment of Inflammatory Bowel Disease: An Application of trans-4-l-Hydroxyprolyl-l-serine.,  65  (6.0): [PMID:34842428] [10.1021/acs.jmedchem.1c01276]

Source